Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at PLN 381.1B, ahead of Eli Lilly (PLN 263.7B) and Merck & Co (PLN 263.1B). Figures as of 20 Nov 2026, 02:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonPLN 381.1B
- Median
- PLN 13B
- Combined market value
- PLN 20.08T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 381.1B | PLN 2.6T | PLN 1,080.92 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | PLN 263.7B | PLN 4.87T | PLN 5,466.97 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | PLN 263.1B | PLN 1.32T | PLN 537.38 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | PLN 253.2B | PLN 635.2B | PLN 111.43 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | PLN 247.5B | PLN 2.03T | PLN 1,147.27 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 237.7B | PLN 1.1T | PLN 709.75 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | PLN 220.7B | PLN 1.16T | PLN 611.87 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | PLN 195.9B | PLN 447.5B | PLN 186.37 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | PLN 195B | PLN 482.5B | PLN 236.06 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | PLN 185.6B | PLN 693.2B | PLN 157.28 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 179.4B | PLN 727.9B | PLN 420.28 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | PLN 175.4B | PLN 387.8B | PLN 193.49 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | PLN 114.2B | PLN 276.8B | PLN 86.63 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 69.8B | PLN 182B | PLN 155.94 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | PLN 58B | PLN 386.5B | PLN 3,736.06 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | PLN 57.9B | PLN 92.2B | PLN 80.44 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | PLN 48.6B | PLN 534.1B | PLN 2,106.72 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | PLN 38.3B | PLN 132.8B | PLN 326.90 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | PLN 33.8B | PLN 22.6B | PLN 33.18 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | PLN 21.6B | PLN 184.7B | PLN 1,617.29 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | PLN 19.1B | PLN 53.2B | PLN 106.38 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 17.3B | PLN 61.4B | PLN 956.74 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | PLN 15.1B | PLN 128.1B | PLN 207.77 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | PLN 15B | PLN 80.1B | PLN 598.12 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 14.5B | PLN 50B | PLN 60.01 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | PLN 13B | PLN 48.1B | PLN 248.52 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | PLN 12.9B | PLN 96.3B | PLN 2,262.26 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | PLN 12.2B | PLN 30.2B | PLN 86.55 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | PLN 9.6B | PLN 157.6B | PLN 274.01 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | PLN 7B | PLN 19.7B | PLN 236.00 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | PLN 6B | PLN 31.4B | PLN 186.86 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | PLN 4.2B | PLN 12.6B | PLN 65.14 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 3.9B | PLN 37.3B | PLN 1,605.31 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | PLN 3.8B | PLN 18.3B | PLN 110.14 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 3.4B | PLN 25B | PLN 176.62 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | PLN 3.2B | PLN 67.9B | PLN 1,035.68 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | PLN 3.1B | PLN 28.8B | PLN 262.93 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 2.7B | PLN 29.7B | PLN 378.47 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | PLN 2.6B | PLN 28.9B | PLN 549.00 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | PLN 2.5B | PLN 39.7B | PLN 262.52 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | PLN 2.5B | PLN 128.2B | PLN 584.52 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | PLN 2.1B | PLN 25.2B | PLN 386.46 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | PLN 2B | PLN 61.6B | PLN 316.34 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | PLN 2B | PLN 18.8B | PLN 195.43 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | PLN 1.1B | PLN 23.2B | PLN 1,161.03 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 767.8M | PLN 32.8B | PLN 472.60 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | PLN 356.2M | PLN 29B | PLN 208.22 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | PLN 186.2M | PLN 32.8B | PLN 501.82 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | PLN 33.4M | PLN 114.2B | PLN 157.64 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | PLN 8.2M | PLN 19.3B | PLN 343.24 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | PLN 0 | PLN 37.5B | PLN 395.04 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | PLN 0 | PLN 35.2B | PLN 1,257.98 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0462 PLN). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (PLN 381.1B), Eli Lilly (PLN 263.7B) and Merck & Co (PLN 263.1B) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 02:17 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of PLN 20.08T as of 20 Nov 2026, 02:17 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.